when starting semaglutide Restarting after 3 months: complete guide to safely getting back on track Know Before Inject | Semaglutide

Wen SM, Dooner Y, Cheng, et al

If retatrutide demonstrates a substantial benefit over alternative therapies, the FDA has the ability to provide priority review, which shortens the standard 10-month review to 6 months

Also, Nooms robust GLP-1 support enables clinical care and a personalized healthy habit and coaching program

Heart failure therapy by GLP-1RAs Although a meta-analysis of large-scale clinical trials suggested that GLP-1RAs reduce heart failure hospitalizations (HHF) by approximately 10% in patients with diabetes at high cardiovascular risk [22, 23], the treatment effects on the risk of HHF in individual trials other than AMPLITUDE-O were not significant (Tables 1, 2)

Eur J Pharmacol 938: 175439

Geier DA, Carmody T, Kern JK, King PG, Geier MR